Loading...
GEN-06 CLINICAL COURSE AFTER TUMOR RECURRENCE OF MGMT HYPERMETHYLATED GLIOBLASTOMA
MGMT methylation in glioblastoma is a biomarker for determining treatment responsiveness and predicting prognosis. We analyzed whether there were differences in the prognosis between glioblastoma with MGMT hypermethylation and other glioblastomas after tumor recurrence. We enrolled 184 patients who...
Na minha lista:
| Udgivet i: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213324/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.035 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|